Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000929638-19-000683
Filing Date
2019-07-16
Accepted
2019-07-16 16:00:48
Documents
2
Group Members
DAVID EINHORNDME ADVISORS GP, LLCDME CAPITAL MANAGEMENT, LP

Document Format Files

Seq Description Document Type Size
1 sch13g.htm SC 13G 102493
2 exhibit991.htm EX-99.1 10373
  Complete submission text file 0000929638-19-000683.txt   114713
Mailing Address 140 EAST 45TH STREET 24TH FLOOR NEW YORK NY 10017
Business Address 140 EAST 45TH STREET 24TH FLOOR NEW YORK NY 10017 2129731900
GREENLIGHT CAPITAL INC (Filed by) CIK: 0001079114 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: SC 13G

Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Subject) CIK: 0001173281 (see all company filings)

EIN.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G | Act: 34 | File No.: 005-82720 | Film No.: 19957238
SIC: 2834 Pharmaceutical Preparations